Quantitative analysis of gentamicin, azithromycin, telithromycin, ciprofloxacin, moxifloxacin, and oritavancin (LY333328) activities against intracellular Staphylococcus aureus in mouse J774 macrophages

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 7, 2003, Pages 2283-2292

  Seral, Cristina ^a   Van Bambeke, Françoise ^a   Tulkens, Paul M ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CIPROFLOXACIN; GENTAMICIN; MOXIFLOXACIN; ORITAVANCIN; OXYTETRACYCLINE; TELITHROMYCIN;

ANIMAL CELL; ARTICLE; BACTERIAL GROWTH; BACTERICIDAL ACTIVITY; CONCENTRATION RESPONSE; GROWTH INHIBITION; MACROPHAGE; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PH; PHAGOCYTOSIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STAPHYLOCOCCUS AUREUS;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; AZA COMPOUNDS; AZITHROMYCIN; CIPROFLOXACIN; FLUOROQUINOLONES; GENTAMICINS; GLYCOPEPTIDES; LYMPHOMA, LARGE-CELL; MACROPHAGES; MICE; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, ELECTRON; QUINOLINES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TUMOR CELLS, CULTURED;

EID: 0038312017     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.7.2283-2292.2003     Document Type: Article

References (64)

1. Alexander, E. H., and M. C. Hudson. 2001. Factors influencing the internalization of Staphylococcus aureus and impacts on the course of infections in humans. Appl. Microbiol. Biotechnol. 56:361-366.
2. al Nawas, B., and P. M. Shah. 1998. Intracellular activity of vancomycin and Ly333328, a new semisynthetic glycopeptide, against methicillin-resistant Staphylococcus aureus. Infection 26:165-167.
3. al Nawas, B., and P. M. Shah. 1998. Intracellular activity of ciprofloxacin and moxifloxacin, a new 8-methoxyquinolone, against methicillin-resistant Staphylococcus aureus. J. Antimicrob. Chemother. 41:655-658.
4. Anderson, R., and G. K. Joone. 1993. In vitro investigation of the intraphagocytic bioactivities of ciprofloxacin and the new fluoroquinolone agents, clinafloxacin (CI-960) and PD 131628. Chemotherapy 39:424-431.
5. Andes, D., and W. A. Craig. 2002. Animal model pharmacokinetics and pharmacodynamics: a critical review. Int. J. Antimicrob. Agents 19:261-268.
6. Bahl, D., D. A. Miller, I. Leviton, P. Gialanella, M. J. Wolin, W. Liu, R. Perkins, and M. H. Miller. 1997. In vitro activities of ciprofloxacin and rifampin alone and in combination against growing and nongrowing strains of methicillin-susceptible and methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 41:1293-1297.
7. Beauchamp, D., P. Gourde, M. Simard, and M. G. Bergeron. 1992. Subcellular localization of tobramycin and vancomycin given alone and in combination in proximal tubular cells, determined by immunogold labeling. Antimicrob. Agents Chemother. 36:2204-2210.
8. Biavasco, F., C. Vignaroli, R. Lupidi, E. Manso, B. Facinelli, and P. E. Varaldo. 1997. In vitro antibacterial activity of LY333328, a new semisynthetic glycopeptide. Antimicrob. Agents Chemother. 41:2165-2172.
9. Carlier, M. B., I. Garcia-Luque, J. P. Montenez, P. M. Tulkens, and J. Piret. 1994. Accumulation, release and subcellular localization of azithromycin in phagocytic and non-phagocytic cells in culture. Int. J. Tissue React. 16:211-220.
10. Carlier, M. B., B. Scorneaux, A. Zenebergh, J. F. Desnottes, and P. M. Tulkens. 1990. Cellular uptake, localization and activity of fluoroquinolones in uninfected and infected macrophages. J. Antimicrob. Chemother. 26(Suppl. B):27-39.
11. Carlier, M. B., A. Zenebergh, and P. M. Tulkens. 1987. Cellular uptake and subcellular distribution of roxithromycin and erythromycin in phagocytic cells. J. Antimicrob. Chemother. 20(Suppl. B):47-56.
12. Carlone, N. A., A. M. Cuffini, M. Ferrero, V. Tullio, and G. Avetta. 1989. Cellular uptake, and intracellular bactericidal activity of teicoplanin in human macrophages. J. Antimicrob. Chemother. 23:849-859.
13. Carryn, S., F. Van Bambeke, M.-P. Mingeot-Leclercq, and P. M. Tulkens. 2002. Comparative intracellular (THP-1 macrophages) and extracellular activities of β-lactams, azithromycin, gentamicin, and fluoroquinolones against Listeria monocytogenes at clinically relevant concentrations. Antimicrob. Agents Chemother. 46:2095-2103.
14. Chambers, H. F. 2000. Penicillins, p. 261-274. In G. L. Mandell, J. E. Bennett, and R. Dolin (ed.), Principles and practice of infectious disease. Churchill Livingstone, Philadelphia, Pa.
15. Cooper, R. D., N. J. Snyder, M. J. Zweifel, M. A. Staszak, S. C. Wilkie, T. I. Nicas, D. L. Mullen, T. F. Butler, M. J. Rodriguez, B. E. Huff, and R. C. Thompson. 1996. Reductive alkylation of glycopeptide antibiotics: synthesis and antibacterial activity. J. Antibiot. (Tokyo) 49:575-581.
16. Craven, N., and J. C. Anderson. 1984. Phagocytosis of Staphylococcus aureus by bovine mammary gland macrophages and intracellular protection from antibiotic action in vitro and in vivo. J. Dairy Res. 51:513-523.
17. Desnottes, J. F., and N. Diallo. 1992. Cellular uptake and intracellular bactericidal activity of RP 59500 in murine macrophages. J. Antimicrob. Chemother. 30(Suppl. A):107-115.
18. Dominguez, M. C., R. M. de La, and M. V. Borobio. 2001. Application of a spectrophotometric method for the determination of post-antibiotic effect and comparison with viable counts in agar. J. Antimicrob. Chemother. 47:391-398.
19. Easmon, C. S., and J. P. Crane. 1985. Uptake of ciprofloxacin by macrophages. J. Clin. Pathol. 38:442-444.
20. Eng, R. H., F. T. Padberg, S. M. Smith, E. N. Tan, and C. E. Cherubin. 1991. Bactericidal effects of antibiotics on slowly growing and nongrowing bacteria. Antimicrob. Agents Chemother. 35:1824-1828.
21. Farr, B. M. 2000. Rifamycins, p. 348-361. In G. L. Mandell, J. E. Bennett, and R. Dolin (ed.), Principles and practice of infectious disease. Churchill Livingstone, Philadelphia, Pa.
22. Fekety, R. 2000. Vancomycin, teicoplanin, and the streptogramins: quinupristin and dalfopristin, p. 382-392. In G. L. Mandell, J. E. Bennett, and R. Dolin (ed.), Principles and practice of infectious disease. Churchill Livingstone, Philadelphia, Pa.
23. Fietta, A., C. Merlini, and G. G. Gialdroni. 1997. Inhibition of intracellular growth of Staphylococcus aureus by exposure of infected human monocytes to clarithromycin and azithromycin. J. Chemother. 9:17-22.
24. Foulds, G., R. M. Shepard, and R. B. Johnson. 1990. The pharmacokinetics of azithromycin in human serum and tissues. J. Antimicrob. Chemother. 25(Suppl. A):73-82.
25. Garcia, I., A. Pascual, S. Ballesta, and E. J. Perea. 2000. Uptake and intracellular activity of ofloxacin isomers in human phagocytic and nonphagocytic cells. Int. J. Antimicrob. Agents 15:201-205.
26. Gilbert, D. N. 2000. Aminoglycosides, p. 307-336. In G. L. Mandell, J. E. Bennett, and R. Dolin (ed.), Principles and practice of infectious disease. Churchill Livingstone, Philadelphia, Pa.
27. Gresham, H. D., J. H. Lowrance, T. E. Caver, B. S. Wilson, A. L. Cheung, and F. P. Lindberg. 2000. Survival of Staphylococcus aureus inside neutrophils contributes to infection. J. Immunol. 164:3713-3722.
28. Kahl, B. C., M. Goulian, W. van Wamel, M. Herrmann, S. M. Simon, G. Kaplan, G. Peters, and A. L. Cheung. 2000. Staphylococcus aureus RN6390 replicates and induces apoptosis in a pulmonary epithelial cell line. Infect. Immun. 68:5385-5392.
29. Kapral, F. A., and M. G. Shayegani. 1959. Intracellular survival of staphylococci. J. Exp. Med. 110:123-128.
30. Lamp, K. C., M. J. Rybak, E. M. Bailey, and G. W. Kaatz. 1992. In vitro pharmacodynamic effects of concentration, pH, and growth phase on serum bactericidal activities of daptomycin and vancomycin. Antimicrob. Agents Chemother. 36:2709-2714.
31. Laurent, G., M. B. Carlier, B. Rollman, F. Van Hoof, and P. Tulkens. 1982. Mechanism of aminoglycoside-induced lysosomal phospholipidosis: in vitro and in vivo studies with gentamicin and amikacin. Biochem. Pharmacol. 31:3861-3870.
32. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265-275.
33. Lowy, F. D. 2000. Is Staphylococcus aureus an intracellular pathogen? Trends Microbiol. 8:341-343.
34. Mandell, G. L., and T. K. Vest. 1972. Killing of intraleukocytic Staphylococcus aureus by rifampin: in-vitro and in-vivo studies. J. Infect. Dis. 125:486-490.
35. Maurin, M., and D. Raoult. 1994. Phagolysosomal alkalinization and intracellular killing of Staphylococcus aureus by amikacin. J. Infect. Dis. 169:330-336.
36. Maurin, M., and D. Raoult. 2001. Use of aminoglycosides in treatment of infections due to intracellular bacteria. Antimicrob. Agents Chemother. 45:2977-2986.
37. Mercier, R. C., C. Stumpo, and M. J. Rybak. 2002. Effect of growth phase and pH on the in vitro activity of a new glycopeptide, oritavancin (LY333328), against Staphylococcus aureus and Enterococcus faecium. J. Antimicrob. Chemother. 50:19-24.
38. Meyer, A. P., C. Bril-Bazuin, H. Mattie, and P. J. van den Broek. 1993. Uptake of azithromycin by human monocytes and enhanced intracellular antibacterial activity against Staphylococcus aureus. Antimicrob. Agents Chemother. 37:2318-2322.
39. Milatovic, D. 1990. Intraphagocytic activity of erythromycin, roxithromycin and azithromycin. Eur. J. Clin. Microbiol. Infect. Dis. 9:33-35.
40. Miossec-Bartoli, C., L. Pilatre, P. Peyron, E.-N. N'Diaye, V. Collart-Dutilleul, I. Maridonneau-Parini, and A. Diu-Hercend. 1999. The new ketolide HMR3647 accumulates in the azurophil granules of human polymorphonuclear cells. Antimicrob. Agents Chemother. 43:2457-2462.
41. Mortimer, P. G., and L. J. Piddock. 1991. A comparison of methods used for measuring the accumulation of quinolones by Enterobacteriaceae, Pseudomonas aeruginosa and Staphylococcus aureus. J. Antimicrob. Chemother. 28:639-653.
42. Namour, F., D. H. Wessels, M. H. Pascual, D. Reynolds, E. Sultan, and B. Lenfant. 2001. Pharmacokinetics of the new ketolide telithromycin (HMR 3647) administered in ascending single and multiple doses. Antimicrob. Agents Chemother. 45:170-175.
43. Nielsen, S. L., N. Obel, M. Storgaard, and P. L. Andersen. 1997. The effect of quinolones on the intracellular killing of Staphylococcus aureus in neutrophil granulocytes. J. Antimicrob. Chemother. 39:617-622.
44. O'Donnell, M. E. 1993. Role of Na-K-Cl cotransport in vascular endothelial cell volume regulation. Am. J. Physiol. 264:C1316-C1326.
45. Ohkuma, S., and B. Poole. 1978. Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents. Proc. Natl. Acad. Sci. USA 75:3327-3331.
46. Paillard, D., J. Grellet, V. Dubois, M. C. Saux, and C. Quentin. 2002. Discrepancy between uptake and intracellular activity of moxifloxacin in a Staphylococcus aureus-human THP-1 monocytic cell model. Antimicrob. Agents Chemother. 46:288-293.
47. Paradisi, F., G. Corti, and D. Messeri. 2001. Antistaphylococcal (MSSA, MRSA, MSSE, MRSE) antibiotics. Med. Clin. N. Am. 85:1-17.
48. Pascual, A., S. Ballesta, I. Garcia, and E. J. Perea. 2001. Uptake and intracellular activity of ketolide HMR 3647 in human phagocytic and nonphagocytic cells. Clin. Microbiol. Infect. 7:65-69.
49. Pascual, A., M. C. Conejo, I. Garcia, and E. J. Perea. 1995. Factors affecting the intracellular accumulation and activity of azithromycin. J. Antimicrob. Chemother. 35:85-93.
50. Pascual, A., I. Garcia, S. Ballesta, and E. J. Perea. 1997. Uptake and intracellular activity of trovafloxacin in human phagocytes and tissue-cultured epithelial cells. Antimicrob. Agents Chemother. 41:274-277.
51. Piddock, L. J., and Y. F. Jin. 1999. Antimicrobial activity and accumulation of moxifloxacin in quinolone-susceptible bacteria. J. Antimicrob. Chemother. 43(Suppl. B):39-42.
52. Rogers, D. E., and R. Tompsett. 1952. The survival of staphylococci within human leukocytes. J. Exp. Med. 95:209-230.
53. Seral, C., J.-M. Michot, H. Chanteux, M.-P. Mingeot-Leclercq, P. M. Tulkens, and F. Van Bambeke. 2003. Influence of P-glycoprotein inhibitors on accumulation of macrolides in j774 murine macrophages. Antimicrob. Agents Chemother. 47:1047-1051.
54. Sullivan, J. T., M. Woodruff, J. Lettieri, V. Agarwal, G. J. Krol, P. T. Leese, S. Watson, and A. H. Heller. 1999. Pharmacokinetics of a once-daily oral dose of moxifloxacin (Bay 12-8039), a new enantiomerically pure 8-methoxy quinolone. Antimicrob. Agents Chemother. 43:2793-2797.
55. Tulkens, P., and A. Trouet. 1978. The uptake and intracellular accumulation of aminoglycoside antibiotics in lysosomes of cultured rat fibroblasts. Biochem. Pharmacol. 27:415-424.
56. Tulkens, P. M. 1991. Intracellular distribution and activity of antibiotics. Eur. J. Clin. Microbiol. Infect. Dis. 10:100-106.
57. Tyteca, D., P. Van Der Smissen, M. Mettlen, F. Van Bambeke, P. M. Tulkens, M. P. Mingeot-Leclercq, and P. J. Courtoy. 2002. Azithromycin, a lysosomotropic antibiotic, has distinct effects on fluid-phase and receptor-mediated endocytosis, but does not impair phagocytosis in J774 macrophages. Exp. Cell Res. 281:86-100.
58. Van Bambeke, F., J. P. Montenez, J. Piret, P. M. Tulkens, P. J. Courtoy, and M. P. Mingeot-Leclercq. 1996. Interaction of the macrolide azithromycin with phospholipids. I. Inhibition of lysosomal phospholipase A1 activity. Eur. J. Pharmacol. 314:203-214.
59. van den Broek, P. J. 1991, Activity of antibiotics against microorganisms ingested by mononuclear phagocytes. Eur. J. Clin. Microbiol. Infect. Dis. 10:114-118.
60. Vazifeh, D., H. Abdelghaffar, and M. T. Labro. 2002. Effect of telithromycin (HMR 3647) on polymorphonuclear neutrophil killing of Staphylococcus aureus in comparison with roxithromycin. Antimicrob. Agents Chemother. 46:1364-1374.
61. Verhoef, J., and F. J. Schmitz. 1999. Staphylococci and other micrococceae, p. 13.1-13.12. In D. Armstrong and J. Cohen (ed.), Infectious diseases. Harcourt Publishers Ltd., London, United Kingdom.
62. Vesga, O., M. C. Groeschel, M. F. Otten, D. W. Brar, J. M. Vann, and R. A. Proctor. 1996. Staphylococcus aureus small colony variants are induced by the endothelial cell intracellular milieu. J. Infect. Dis. 173:739-742.
63. Waldvogel, F. A. 2000. Staphylococcus aureus, p. 2069-2092. In G. L. Mandell, J. E. Bennett, and R, Dolin (ed.), Principles and practice of infectious diseases. Churchill Livingstone, Philadelphia, Pa.
64. Yamamoto, T., H. Kusajima, M. Hosaka, and H. Shinoda. 1995. Uptake and intracellular activity of fleroxacin in phagocytic cells. Chemotherapy 41:353-359.